Not a gestapo policy. Harm reduction in the context of human frailty.

OPIOID STEWARDSHIP

Opioid stewardship here is harm reduction, not enforcement. For irreversible pain, the goal is not zero opioids. It is the minimum effective exposure with function preserved. This page exists for one reason. A regenerative medicine practice that says nothing about opioids is dodging the central question its patients live with.

Is the goal to get me off opioids completely?

For irreversible pain, the goal is not zero opioids. It is the minimum effective exposure with function preserved and harm prevented. That is harm reduction in the context of human frailty. It is not an abstinence policy, and it is not enforcement.

Two failures are possible here, not one. Careless prescribing has done enormous damage. So has the reaction to it. Patients were tapered suddenly by clinicians protecting themselves. People with real, irreversible pain were treated as suspects. And people were pushed off a cliff they were standing near, with the result you would expect. Untreated severe pain can kill on its own. Both failures are real. Pretending only one exists is how people get hurt.

How that shapes what happens here

• We do not require you to come off opioids to be treated.
• We do not treat a dose as a character judgment.
• Where an interventional or regenerative option can widen the window in which you can move, sleep and work, we try that before raising a dose.
• Where it cannot, we say so instead of selling you a series of injections.

Why the metabolic work belongs in this conversation

The aim of the behavioral and metabolic side of the protocol is not virtue. It is retraining a nervous system to rely on its own endogenous endorphins (the body’s own painkillers) instead of exogenous (outside) opioids. That requires three things. Sleep architecture that works. Inflammatory load that is falling, not rising. And enough restored function that movement is possible. Isolation and money pressure work directly against all three. That is why we ask about them here instead of treating them as background noise.

This is not a substitute for addiction treatment where that is what is needed, and we will say so directly if it is.

What does opioid stewardship mean?

“Stewardship” has been used to describe policies that amount to enforcement. Think forced tapers, dose ceilings set without looking at the person, and patients discharged for a single slip. That is not what is meant here. In the words this practice actually uses, it is not a gestapo policy — harm reduction in the context of human frailty.

The difference is practical, not just words. A policy aimed at cutting a number produces patients who hide what they take, get it elsewhere, or are abandoned when they are least able to cope. A practice aimed at restoring function brings up the dose conversation as a result, usually without an argument.

The two failures, held at the same time

Careless prescribing caused enormous harm, and that is not in dispute. What is said less often is that the correction caused harm of its own. Clinicians protecting themselves drove sudden tapers. People with irreversible pain were treated as suspects. And there was a well-documented rise in crisis among patients taken off against their will.

Untreated severe pain can kill on its own. It does so through strain on the heart, through immobility and its metabolic effects, and through suicide. A position that admits only one of these two failures is not a clinical position. It is a reputational one.

Why function is the target rather than the number

The reasoning is physiological, not moral. The aim is to retrain a nervous system to rely on its own endogenous endorphins instead of exogenous opioids. That requires three things a person in constant pain usually does not have.

• Sleep architecture that works. Most tissue repair signaling happens at night. Broken sleep raises inflammation and lowers the pain threshold. Opioids themselves disrupt sleep architecture, which is part of the trap.
• Falling rather than rising inflammatory load. Chronic metabolic inflammation turns up nociceptive (pain) signaling. Immobility raises it; movement lowers it.
• Enough restored function that movement is possible at all. This is what an interventional or regenerative treatment can honestly provide: a window.

Isolation and money pressure work directly against all three. That is why we ask about them here instead of treating them as background. Picture someone working double shifts to cover rent, sleeping five hours, with no one to help them. They will not out-discipline that situation with a taper schedule.

What you can count on here

• Treatment without a required taper.
• Your current dose treated as a clinical fact, not a character question.
• Honesty with us that never costs you your care.
• A straight account of what a regenerative treatment can fix and what it cannot.
• Advertising that never targets people searching for opioids. This field does that. This practice does not.

Where this practice draws a real line

Sometimes the problem is an opioid use disorder, not a pain problem being managed with opioids. That needs addiction treatment, and we will say so directly. Those are different conditions with different treatments, and blurring them helps nobody. Dr. Gurpreet Singh Padda, MD, MBA, MHP is an addiction medicine specialist. So this distinction is made from inside the field, not at arm’s length from it.

Saying it plainly is part of the point. A patient who suspects they are quietly being assessed for a diagnosis nobody will name will not tell you the truth about anything.

Related reading

• Injury and work comp
• Still in pain after back surgery
• How PRP works
• Am I a candidate?
• About Dr. Padda
• Information for referring physicians

What happens at a first appointment if I am on opioids?

Bring the actual list, including doses. Nobody is going to react to it. An accurate picture is the only thing that makes the rest of the conversation useful.

We will want to know what the medicine does for you in daily life. What can you do on it that you could not do without it? We ask because that is the measure that matters, and it is rarely the one recorded. We will want to know about sleep, because opioids break it up and broken sleep makes pain worse. That loop is often easier to change than the dose.

If a regenerative option is a reasonable bet for your problem, we will say so and treat it. If it is not, we will say that instead of taking your money. And we will still try to be useful about what else might help.

Frequently asked questions about opioids and treatment here

Will you make me taper before treating me?

No. That is not a condition of care here. How we assess candidacy.

Do you prescribe opioids?

This is a pain practice, and prescribing is part of it, within the position described above. Contact us.

What if I think I have a problem with them?

Say so. It moves the plan toward treatment, not judgment. About Dr. Padda.

Can PRP get me off pain medication?

Sometimes it widens the window enough that the question answers itself. It is not a promise. How PRP works.

Can you take opioids long term for chronic pain?

For irreversible pain, the goal here is not zero opioids. It is the minimum effective dose with function preserved and harm prevented. Long-term use has real costs. Opioids break up sleep, and broken sleep makes pain worse. Meanwhile the reward system resets, so the same dose does less over time. The question we ask is what the medicine lets you do that you could not do without it.

Is it dangerous to be cut off opioids suddenly?

It can be. Careless prescribing did enormous harm, and so did the reaction to it. Clinicians protecting themselves pushed sudden tapers. There was a well-documented rise in crisis among patients stopped against their will. Untreated severe pain carries its own risks, including heart strain, immobility and suicide. That is why this practice does not require a taper as a condition of treating you.

Will I be discharged for being honest about what I take?

No. Being honest with us is never a reason to discharge you. Your current dose is not treated as a character question. Bring the actual list, including doses. Nobody will react to it. An accurate picture is the only thing that makes the rest of the conversation useful. A patient who fears judgment will not tell the truth about anything.

How many patients get off opioids with interventional treatment?

Dr. Padda’s interventional practice reports on the patients who arrive. On average, they have been in pain for more than two and a half years. They take above 90 morphine milligram equivalents a day. Of those, 21% are completely off opioid pain medication within 90 days of active interventional treatment, and 34% within one year. These are practice-reported figures from our own population, not trial outcomes, and individual results vary.

Why a regenerative clinic writes this page at all

Most clinics selling PRP say nothing about opioids. That silence makes business sense, because the subject draws scrutiny and complicated patients. It appears here for a reason. The people most likely to ask about regenerative treatment are often the same people who have been managed for years on rising doses of painkillers. They have been told there is nothing more to offer.

That group is vulnerable to exactly the kind of overselling this field produces. Saying plainly what a treatment can and cannot do, to someone in that spot, is a stewardship act in itself. Here is why. The worst outcome is not that a treatment fails. It is that someone spends what they have and decides everything has now been tried. Then they go back to a rising dose as the only option left.

Why the dose was ever the whole conversation

Symptom-based silos are the reason. Pain goes to one specialty, blood sugar to another, sleep to nobody, and weight to a lecture. Each silo tunes its own number. No one owns the collision. And the only tool that spans all of them is a prescription.

That is medicalization doing what it does: milking the cow rather than curing the cow. It is not a claim that anyone acted badly. It is a description of what a system built on fifteen-minute visits and procedure codes will reliably produce.

Why does the same opioid dose stop working over time?

Long-term exogenous opioid exposure recalibrates dopaminergic drive (the brain’s reward wiring). The receptor system once responded to a meal, a walk, a conversation. Now it gets reset to a higher baseline, and everything below that line stops registering. This is the hedonic treadmill. It is why the dose that worked in March does less in September, without anyone doing anything wrong.

It also explains why subtraction alone fails. Take the drug away and you have not restored the reward system. You have removed the only thing still reaching it. The work that actually helps is hedonic substitution. That means rebuilding the endogenous signals that movement, sleep, food timing and human contact produce. Then there is something on the other side of the taper besides absence.

That is the physiological argument for why lifestyle work is 40 to 50 percent of the protocol here, not advice at discharge. It is not encouragement. It is the replacement signal.

The enemy in this story

Not the patient. And not the physician who prescribed in good faith under guidance that later reversed. The enemy is a set of incentives. One is a food supply engineered against dopamine circuitry. Another is a payment system that funds the injection and not the hour of behavioral work. A third is an isolation epidemic that nobody codes for.

Loneliness belongs on that list and is usually left off it. Social disconnection raises inflammatory markers and lowers pain thresholds. It does this through mechanisms as measurable as any drug effect. A person in pain who is also alone is not living with two separate problems.

What the numbers look like where this is practiced

Dr. Padda’s interventional practice published its own opioid figures on International Overdose Awareness Day, August 31, 2026. The average new patient arrives after more than two and a half years in pain and above 90 morphine milligram equivalents a day. 21% are completely off opioid pain medication within 90 days of active interventional treatment, and 34% within one year. Of those who cannot be fully weaned, the large majority are brought below 30 MME per day. These are practice-reported figures from that population, not trial outcomes, and individual results vary.

The point of publishing them is the mechanism, not the math. A taper lowers a dose. Treating the structure that is creating the pain changes why the dose was there. Read the release on AP News or in the original announcement.